Return On Equity of Vir Biotechnology, Inc. from 30 Sep 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vir Biotechnology, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2022 to 30 Sep 2025.
  • Vir Biotechnology, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -51%, a 38% decline year-over-year.
  • Vir Biotechnology, Inc. annual Return On Equity for 2024 was -39%, a 11% decline from 2023.
  • Vir Biotechnology, Inc. annual Return On Equity for 2023 was -35%, a 238% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Vir Biotechnology, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -51% -14% -38% 01 Jul 2025 30 Sep 2025
Q2 2025 -50% -19% -62% 01 Apr 2025 30 Jun 2025
Q1 2025 -47% -15% -46% 01 Jan 2025 31 Mar 2025
Q4 2024 -39% -4% -11% 01 Oct 2024 31 Dec 2024
Q3 2024 -37% -5% -15% 01 Jul 2024 30 Sep 2024
Q2 2024 -31% -18% -136% 01 Apr 2024 30 Jun 2024
Q1 2024 -33% -26% -362% 01 Jan 2024 31 Mar 2024
Q4 2023 -35% -60% -238% 01 Oct 2023 31 Dec 2023
Q3 2023 -32% -93% -153% 01 Jul 2023 30 Sep 2023
Q2 2023 -13% 01 Apr 2023 30 Jun 2023
Q1 2023 -7% 01 Jan 2023 31 Mar 2023
Q4 2022 25% 01 Oct 2022 31 Dec 2022
Q3 2022 61% 01 Jul 2022 30 Sep 2022

Vir Biotechnology, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -39% -4% -11% 01 Jan 2024 31 Dec 2024
2023 -35% -60% -238% 01 Jan 2023 31 Dec 2023
2022 25% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.